Tiziana Life Sciences (TLSA)
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory dise...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Tiziana Life Sciences Analyst Rating
View moreForecast & Rating
Sep 3, 2026Price forecast
$8.01734.43%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · Sep 11 at 05:11 AM
Tiziana Life Sciences (TLSA) Expected to Post Quarterly Earnings on Friday
- benzinga_article · Sep 3 at 12:10 PM
This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
- Global Report · Sep 3 at 10:12 AM
Global Crosscurrents and Macro Shifts Fragment US Thematic Equities in 2026
- PUBT · Aug 24 at 11:00 AM
Tiziana Life Sciences launches Phase 2a BANYAN trial of intranasal foralumab in ALS
